HETERO LABS LTD III FDA Approval ANDA 201450

ANDA 201450

HETERO LABS LTD III

FDA Drug Application

Application #201450

Application Sponsors

ANDA 201450HETERO LABS LTD III

Marketing Status

Prescription001

Application Products

001SOLUTION;ORALEQ 10MG BASE/5ML0CITALOPRAM HYDROBROMIDECITALOPRAM HYDROBROMIDE

FDA Submissions

N/A; Not ApplicableORIG1AP2015-12-15
LABELING; LabelingSUPPL3AP2020-04-20STANDARD
LABELING; LabelingSUPPL4AP2021-09-21STANDARD

Submissions Property Types

ORIG1Null7
SUPPL3Null15
SUPPL4Null15

TE Codes

001PrescriptionAA

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 201450
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"CITALOPRAM HYDROBROMIDE","activeIngredients":"CITALOPRAM HYDROBROMIDE","strength":"EQ 10MG BASE\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/15\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"04\/20\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-04-20
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.